RenovoRx, Inc. (RNXT)
1.33
-0.16
(-10.74%)
USD |
NASDAQ |
Oct 30, 15:05
RenovoRx Cash and Short Term Investments (Annual) : 7.024M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 7.024M |
| December 31, 2024 | 7.154M |
| December 31, 2023 | 1.173M |
| December 31, 2022 | 6.44M |
| Date | Value |
|---|---|
| December 31, 2021 | 15.19M |
| December 31, 2020 | 1.795M |
| December 31, 2019 | 2.124M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Enanta Pharmaceuticals, Inc. | 188.86M |
| Travere Therapeutics, Inc. | 322.80M |
| REGENXBIO, Inc. | 230.07M |
| Krystal Biotech, Inc. | 827.79M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |